Vagus nerve paraganglioma
disease diseaseOn this page
Also known as paraganglioma of the vagal bodyparaganglioma of the vagus nerveparaganglioma of vagal bodyparaganglioma of vagus nervevagal body paragangliomavagal paraganglioma
Summary
Vagus nerve paraganglioma (MONDO:0044768) is a disease. A subtype of vagus nerve neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | vagus nerve paraganglioma |
| Mondo ID | MONDO:0044768 |
| NCIT | C8427 |
| SNOMED CT | 253030004 |
| UMLS | C0474819 |
| MedGen | 141635 |
| GARD | 0008620 |
| Anatomy (UBERON) | UBERON:0001759 |
| Is cancer (heuristic) | no |
Also known as: paraganglioma of the vagal body · paraganglioma of the vagus nerve · paraganglioma of vagal body · paraganglioma of vagus nerve · vagal body paraganglioma · vagal paraganglioma · vagus nerve paraganglioma
Disease family
This is a subtype of vagus nerve neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › nervous system disorder › cranial nerve neuropathy › glossopharyngeal nerve disorder › vagus nerve disorder › vagus nerve neoplasm › vagus nerve paraganglioma
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.